A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System (NCT07227532)
BWI202405: Assessment of Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the VARIPULSE™ Catheter System
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Who can join: Review the eligibility criteria below.
Location: Phoenix Cardiovascular Research Group — Phoenix, Arizona
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (23 Sites)
- Phoenix Cardiovascular Research Group — Phoenix, Arizona
- Tucson Medical Center Pima Heart and Vascular — Tucson, Arizona
- OC Memorial — Fountain Valley, California
- San Diego Cardiac Center — San Diego, California
- Stanford Hospital and Clinics — Stanford, California
- Community Memorial Hospital — Ventura, California
- Aurora Denver Cardiology Associates — Aurora, Colorado
- Colorado Heart and Vascular PC — Golden, Colorado
- HCA Florida Mercy Hospital — Miami, Florida
- Orlando Health Heart and Vascular Institute — Orlando, Florida
- Deaconess Gateway Hospital — Newburgh, Indiana
- The Kansas City Heart Rhythm Institute — Overland Park, Kansas
- Norton Heart and Vascular Institute — Louisville, Kentucky
- Trinity Health — Ypsilanti, Michigan
- Mayo Clinic Rochester — Rochester, Minnesota
- Albert Einstein College Of Medicine - Montefiore Medical Center — The Bronx, New York
- The Christ Hospital — Cincinnati, Ohio
- Springfield Medical Center — Springfield, Ohio
- Texas Cardiac Arrhythmia Research Foundation — Austin, Texas
- Baylor Scott and White Research Institute — Fort Worth, Texas
- Baylor Scott & White Research Institute at The Heart Hospital Baylor Plano — Plano, Texas
- Winchester Medical Center — Winchester, Virginia
- Mercy Hospital — Janesville, Wisconsin
📞 Contact the Study Coordinator
Phone: (949) 230-3701
Email: EPurcel1@its.jnj.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation
- CHAMPION-AF Clinical Trial — Birmingham, Alabama
- Reversal of Atrial Substrate to Prevent Atrial — Calgary, Alberta
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients — Rochester, New York
- REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry — Chandler, Arizona
- Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) — Cleveland, Ohio
- Liraglutide Effect in Atrial Fibrillation — Miami, Florida
Explore by condition: All Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.